Influence of hypoxia-inducible factor 1α on dendritic cell differentiation and migration
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Dendritic cells(DCs) are important sentinels of the immune system and frequently reside in areas of low oxygen availability, in particular in the course of inflammatory processes. Hypoxia-inducible transcription factor (HIF)1α is responsible for major alterations in gene expression as part of the cellular adaptation to low oxygen concentration. In this study, we generated mice with a conditional deletion of HIF1α in DCs. Bone marrow-derived DCs from WT and conditional mutant mice expressed elevated levels of major histocompatibility complex class II and CD86 when grown in a hypoxic environment, whereas production of the cytokines interleukin (IL)-12p70, IL-10, IL-6, TNF-α, IL-1β, and IL-23 was reduced, both independent of HIF1α expression. In contrast, secretion of IL-22 was strongly enhanced under hypoxic conditions in an HIF1α-dependent manner. The chemokine receptor CCR7 was expressed at higher levels in wild-type DCs compared with HIF1α-deficient DCs, whereas the production of CCL17 and CCL22 was increased in conditions of low oxygen. Using in vitro as well as in vivo migration assays, we observed an enhanced migratory capability of DCs generated under hypoxia, which was HIF1α-dependent. Taken together, our data indicate that HIF1α plays an important role for DC differentiation and migration in a low oxygen environment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In dendritic cells (DC), HIF1 a supports maturation, activation, migration, and antigen presentation (Bhandari et al., 2013; Jantsch et al., 2008; Ko ¨ hler et al., 2012; Pantel et al., 2014).”
From Ferritin-Mediated Iron Sequestration Stabilizes Hypoxia-Inducible Factor-1α upon LPS Activation in the Presence of Ample Oxygen (2015) · cites this paper as Köhler et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunobiology of Dendritic Cells
Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.-J., Pulendran, B., & Palucka, K. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.767 · Cited by 6,634
Semenza, G. L., & Wang, G. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5447 · Cited by 2,617
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476
HIF-1α is essential for myeloid cell-mediated inflammation
Cramer, T., Yamanishi, Y., Clausen, B. E., Förster, I., Pawlinski, R., Mackman, N., Haase, V. H., Jaenisch, R., Corr, M., Nizet, V., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00154-5 · Cited by 2,046
Self-citationInterleukin-22 mediates early host defense against attaching and effacing bacterial pathogens
Zheng, Y., Valdez, P. A., Danilenko, D. M., Hu, Y., Sa, S. M., Gong, Q., Abbas, A. R., Modrusan, Z., Ghilardi, N., de Sauvage, F. J., et al. (2008) · Nature Medicine · doi:10.1038/nm1720 · Cited by 1,921
Shi, L. Z., Wang, R., Huang, G., Vogel, P., Neale, G., Green, D. R., & Chi, H. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110278 · Cited by 1,803
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
Dang, E. V., Barbi, J., Yang, H.-Y., Jinasena, D., Yu, H., Zheng, Y., Bordman, Z., Fu, J., Kim, Y., Yen, H.-R., et al. (2011) · Cell · doi:10.1016/j.cell.2011.07.033 · Cited by 1,595
Differential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation
Hu, C.-J., Wang, L.-Y., Chodosh, L. A., Keith, B., & Simon, M. C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.9361-9374.2003 · Cited by 1,386
Steady-state and inflammatory dendritic-cell development
Shortman, K., & Naik, S. H. (2007) · Nature Reviews Immunology · doi:10.1038/nri1996 · Cited by 1,190
IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia
Aujla, S. J., Chan, Y. R., Zheng, M., Fei, M., Askew, D. J., Pociask, D. A., Reinhart, T. A., McAllister, F., Edeal, J., Gaus, K., et al. (2008) · Nature Medicine · doi:10.1038/nm1710 · Cited by 1,171
Cited by
The role of HIF in immunity and inflammation
McGettrick, A. F., & O’Neill, L. A. J. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.08.002 · Cited by 768
Dendritic cell migration in inflammation and immunity
Liu, J., Zhang, X., Cheng, Y., & Cao, X. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00726-4 · Cited by 537
“Hypoxia-generated DCs show increased migratory ability, which is dependent on HIF-1α, as evidenced by the reduced migration to CCL19 of HIF-1αdeficient DCs compared with wild-type DCs under hypoxic conditions [92].”
BackgroundHypoxia‐inducible factors in regulation of immune responses in tumour microenvironment
Kumar, V., & Gabrilovich, D. I. (2014) · Immunology · doi:10.1111/imm.12380 · Cited by 329
Wang, B., Zhao, Q., Zhang, Y., Liu, Z., Zheng, Z., Liu, S., Meng, L., Xin, Y., & Jiang, X. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01820-7 · Cited by 315
“Moreover, hypoxia could impair mature DC migration to the lymph nodes via the downregulation of CCR7 by HIF-1α-dependent mechanisms [36].”
BackgroundImmunity, Hypoxia, and Metabolism–the Ménage à Trois of Cancer: Implications for Immunotherapy
Riera-Domingo, C., Audigé, A., Granja, S., Cheng, W.-C., Ho, P.-C., Baltazar, F., Stockmann, C., & Mazzone, M. (2020) · Physiological Reviews · doi:10.1152/physrev.00018.2019 · Cited by 310
Hypoxia-Driven Immune Escape in the Tumor Microenvironment
Vito, A., El-Sayes, N., & Mossman, K. (2020) · Cells · doi:10.3390/cells9040992 · Cited by 270
“Similar to PD-L1, hypoxia has been shown to upregulate the expression of CD86 on DCs in a HIF-1α-dependent manner [100].”
BackgroundTargeting innate immune pathways for cancer immunotherapy
Cao, L. L., & Kagan, J. C. (2023) · Immunity · doi:10.1016/j.immuni.2023.07.018 · Cited by 216
Hypoxia-dependent regulation of inflammatory pathways in immune cells
Taylor, C. T., Doherty, G., Fallon, P. G., & Cummins, E. P. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84433 · Cited by 220
Immunometabolism in systemic lupus erythematosus
Morel, L. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.43 · Cited by 219
Metabolic Control of Dendritic Cell Functions: Digesting Information
Wculek, S. K., Khouili, S. C., Priego, E., Heras-Murillo, I., & Sancho, D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00775 · Cited by 215
“In line, GM-DCs in the steady state express higherMHCII and co-stimulatorymolecule levels in hypoxic conditions (14).”
Hypoxia, Metabolism and Immune Cell Function
Krzywinska, E., & Stockmann, C. (2018) · Biomedicines · doi:10.3390/biomedicines6020056 · Cited by 208
Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma
Daniel, S. K., Sullivan, K. M., Labadie, K. P., & Pillarisetty, V. G. (2019) · Clinical and Translational Medicine · doi:10.1186/s40169-019-0226-9 · Cited by 207
“It is not certain if DCs have decreased migration and phagocytic capabilities in a hypoxic environment [163, 164].”
BackgroundMechanisms of Hypoxia-Mediated Immune Escape in Cancer
Barsoum, I. B., Koti, M., Siemens, D. R., & Graham, C. H. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-2598 · Cited by 201
Glucose represses dendritic cell-induced T cell responses
Lawless, S. J., Kedia-Mehta, N., Walls, J. F., McGarrigle, R., Convery, O., Sinclair, L. V., Navarro, M. N., Murray, J., & Finlay, D. K. (2017) · Nature Communications · doi:10.1038/ncomms15620 · Cited by 181
The role of HIF in immunity and inflammation
Cummins, E. P., Keogh, C. E., Crean, D., & Taylor, C. T. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2015.12.004 · Cited by 150
“alterations in the expression of other cytokines independent of HIF-1 [53].”
BackgroundImmune Response Regulation in the Tumor Microenvironment by Hypoxia
Labiano, S., Palazón, A., & Melero, I. (2015) · Seminars in Oncology · doi:10.1053/j.seminoncol.2015.02.009 · Cited by 168
HIF in the heart: development, metabolism, ischemia, and atherosclerosis
Knutson, A. K., Williams, A. L., Boisvert, W. A., & Shohet, R. V. (2021) · Journal of Clinical Investigation · doi:10.1172/jci137557 · Cited by 161
Sirtuin deacylases: a molecular link between metabolism and immunity
Preyat, N., & Léo, O. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1112557 · Cited by 141
Tang, Y., Wang, D., Wang, Y., Huang, A., & Xu, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1073971 · Cited by 152
Intestinal hypoxia and hypoxia-induced signalling as therapeutic targets for IBD
Welden, S. V., Selfridge, A. C., & Hindryckx, P. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.101 · Cited by 132
Hypoxia in Solid Tumors: How Low Oxygenation Impacts the “Six Rs” of Radiotherapy
Rakotomalala, A., Escande, A., Furlan, A., Meignan, S., & Lartigau, E. F. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.742215 · Cited by 128
Hasmim, M., Noman, M. Z., Messai, Y., Bordereaux, D., Gros, G., Baud, V., & Chouaib, S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1302140 · Cited by 109
“Furthermore, we did not observe any effect of Nanog targeting on hypoxia-induced chemokines CCL22 (16, 17) and CCL28 (13) shown to regulate Treg infiltration (data not shown).”
BackgroundFlück, K., Breves, G., Fandrey, J., & Winning, S. (2015) · Mucosal Immunology · doi:10.1038/mi.2015.67 · Cited by 122
Siegert, I., Schödel, J., Nairz, M., Schatz, V., Dettmer, K., Dick, C., Kalucka, J., Franke, K., Ehrenschwender, M., Schley, G., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.11.005 · Cited by 110
Hypoxia/HIF Modulates Immune Responses
Chen, Y., & Gaber, T. (2021) · Biomedicines · doi:10.3390/biomedicines9030260 · Cited by 119
Interleukin-22 promotes tumor angiogenesis
Protopsaltis, N. J., Liang, W. P., Nudleman, E., & Ferrara, N. (2018) · Angiogenesis · doi:10.1007/s10456-018-9658-x · Cited by 103
Li, X., Feng, Y., Liu, J., Feng, X., Zhou, K., & Tang, X. (2013) · Lifestyle Genomics · doi:10.1159/000354402 · Cited by 66
Hammami, A., Charpentier, T., Smans, M., & Stäger, S. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004938 · Cited by 64
Filippi, I., Morena, E., Aldinucci, C., Carraro, F., Sozzani, S., & Naldini, A. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24666 · Cited by 58
“We have previously shown that HIF-1a is involved in cell migration induced by hypoxia in breast cancer cells (Naldini et al., 2010) and recent reports demonstrated that HIF-1a is actively involved in modulating dendritic cell survival (Naldini et al., 2012b) and migration (Kohler et al., 2012).”
BackgroundSen, K., Pati, R., Jha, A., Mishra, G. P., Prusty, S., Chaudhary, S., Swetalika, S., Podder, S., Sen, A., Swain, M., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102575 · Cited by 60
Chang, W. H., & Lai, A. G. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.05.011 · Cited by 55
de Oliveira, J., Denadai, M. B., & Costa, D. L. (2022) · Antioxidants · doi:10.3390/antiox11050861 · Cited by 67
Strategies to overcome DC dysregulation in the tumor microenvironment
Mestrallet, G., Sone, K., & Bhardwaj, N. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.980709 · Cited by 57
“HIF1a enhanced DCmigration and IL-22 production under hypoxic conditions (60) but limited precursor differentiation into pDCs (61).”
BackgroundDendritic cells and adipose tissue
Rajan, S. S., & Longhi, M. P. (2016) · Immunology · doi:10.1111/imm.12653 · Cited by 54
Hypoxia-inducible factor-1α regulation of myeloid cells
Stothers, C. L., Luan, L., Fensterheim, B. A., & Bohannon, J. K. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1710-1 · Cited by 57
Han, Z., Dong, Y., Lu, J., Yang, F., Zheng, Y., & Yang, H. (2021) · American Journal of Cancer Research · Cited by 63
Sun, L., Li, T., Tang, H., Yu, K., Ma, Y., Yu, M., Qiu, Y., Xu, P., Xiao, W., & Yang, H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00806 · Cited by 49
“As with myeloid cells, DCs are also regulated by HIF1α in cell differentiation, migration and survival (44).”
BackgroundWinning, S., & Fandrey, J. (2016) · Journal of Immunology Research · doi:10.1155/2016/5134329 · Cited by 49
“Until now, several groups have analyzed DC function under hypoxic conditions.”
Hypoxia‐inducible factors in metabolic reprogramming during sepsis
Vanderhaeghen, T., Vandewalle, J., & Libert, C. (2020) · FEBS Journal · doi:10.1111/febs.15222 · Cited by 51
Targeting intratumoral hypoxia to enhance anti-tumor immunity
Semenza, G. L. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.09.002 · Cited by 53
Implications of cellular metabolism for immune cell migration
Guak, H., & Krawczyk, C. M. (2020) · Immunology · doi:10.1111/imm.13260 · Cited by 47
Hypoxia and hypoxia-inducible factors in myeloid cell-driven host defense and tissue homeostasis
Jantsch, J., & Schödel, J. (2015) · Immunobiology · doi:10.1016/j.imbio.2014.09.009 · Cited by 46
The transcription factor NR4A3 controls CD103+ dendritic cell migration
Park, K., Mikulski, Z., Seo, G., Andreyev, A. Y., Marcovecchio, P., Blatchley, A., Kronenberg, M., & Hedrick, C. C. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87081 · Cited by 47
Cardoso, M. S., Silva, T. M., Resende, M., Appelberg, R., & Borges, M. C. (2015) · Infection and Immunity · doi:10.1128/iai.00144-15 · Cited by 47
“HIF-1 also plays a role in T cells (28), B cells (29), neutrophils (30), or dendritic cells (DCs) (31, 32) and regulates the differentiation of Th17 cells and regulatory T cells (33, 34) and the production of proinflammatory cytokines in response to T cell receptor activation (28).”
BackgroundUnderstanding the tumour micro‐environment communication network from an NOS2/COX2 perspective
Basudhar, D., Bharadwaj, G., Somasundaram, V., Cheng, R. Y. S., Ridnour, L. A., Fujita, M., Lockett, S., Anderson, S. K., McVicar, D. W., & Wink, D. A. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14488 · Cited by 45
“Moreover, HIF-1α also plays a crucial role in the differentiation and migration of DCs generated under hypoxia (Kohler et al., 2012).”
BackgroundPerspectives on Hypoxia Signaling in Tumor Stroma
Zhang, Y., Coleman, M., & Brekken, R. A. (2021) · Cancers · doi:10.3390/cancers13123070 · Cited by 39
Hypoxia-inducible factor 1 alpha limits dendritic cell stimulation of CD8 T cell immunity
Tran, C. W., Gold, M. J., Garcia-Batres, C. R., Tai, K., Elford, A. R., Himmel, M. E., Elia, A., & Ohashi, P. S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0244366 · Cited by 40
“We generated BMDC by culturing bone marrow PLOS ONE | https://doi.org/10.1371/journal.pone.0244366 December 31, 2020 2 / 15 Competing interests: The authors have declared that no competing interests exist. https://doi.org/10.1371/journal.pone.0244366.g001 PLOS ONE | https://doi.org/10.1371/journal.pone.0244366 Decembe…”
BackgroundInfluentialHsu, Y., Wang, M., Ho, L., Huang, C., & Lai, J. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12500 · Cited by 39
Cellular Stress Responses and Gut Microbiota in Inflammatory Bowel Disease
Cao, S. “. (2018) · Gastroenterology Research and Practice · doi:10.1155/2018/7192646 · Cited by 41
Immunometabolic cross-talk in the inflamed heart
Marelli‐Berg, F. M., & Aksentijević, D. (2019) · Cell Stress · doi:10.15698/cst2019.08.194 · Cited by 37
“HIF1α is expressed by most immune cell populations including macrophages, neutrophils, DCs, as well in T and B lymphocytes and innate lymphoid cells [182].”
BackgroundInfluentialIntestinal oxygen utilisation and cellular adaptation during intestinal ischaemia–reperfusion injury
Barakakis, P. A., Mavridis, T., Chlorogiannis, D., Barakakis, G., Laou, E., Sessler, D. I., Gkiokas, G., & Chalkias, A. F. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.70136 · Cited by 34
Transcription Factor HIF-1α Controls Expression of the Cytokine IL-22 in CD4 T Cells
Budda, S. A., Girton, A. W., Henderson, J. G., & Zenewicz, L. A. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600250 · Cited by 35
“reported to upregulate IL-22 expression under hypoxia (27), suggesting that there may be conserved pathways in the hypoxic induction of IL-22.”
BackgroundXiao, J., Guo, X., & Wang, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1385907 · Cited by 36
Dendritic cells: understanding ontogeny, subsets, functions, and their clinical applications
Li, W., Yu, C., Zhang, X., Gu, Y., He, X., Xu, R., Xu, J. F., Yu, G., & Wu, Y. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00300-8 · Cited by 30
“Hypoxia triggers DCs to upregulate HIF-1α, which shifts metabolism toward glycolysis while suppressing OXPHOS [78, 79] and stimulating pro-inflammatory cytokine secretion (TNF-α, IL-6, IL-1β) [357, 358].”
Positron emission tomography imaging sheds new light on hypoxia and antitumor therapies
Fang, H., Wang, X., Lan, X., & Jiang, D. (2023) · Interdisciplinary medicine · doi:10.1002/inmd.20230002 · Cited by 31
the STARTING-2 trial investigators, Bang, O. Y., Moon, G. J., Kim, D. H., Lee, M. J., Kim, S., Son, J. P., Cho, Y. H., Chang, W. H., & Kim, Y. (2017) · Translational Stroke Research · doi:10.1007/s12975-017-0538-2 · Cited by 30
Sirtuins in Multiple Sclerosis: The crossroad of neurodegeneration, autoimmunity and metabolism
Foolad, F., Khodagholi, F., & Javan, M. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.06.004 · Cited by 28
Mechanisms controlling bacterial infection in myeloid cells under hypoxic conditions
Hayek, I., Schatz, V., Bogdan, C., Jantsch, J., & Lührmann, A. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03684-8 · Cited by 27
Cui, F., Wu, J., Shen, Y., Hu, H., Wang, Q., Mao, Y., Ye, B., & Xiang, M. (2021) · Cancer Medicine · doi:10.1002/cam4.4511 · Cited by 25
Hypoxia-Inducible Factor-1α and Autoimmune Lupus, Arthritis
Yang, Z., & Liu, Y. (2016) · Inflammation · doi:10.1007/s10753-016-0337-z · Cited by 24
Determinants of hypoxia-inducible factor activity in the intestinal mucosa
Fagundes, R. R., & Taylor, C. T. (2017) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00203.2017 · Cited by 27
Hypoxia, Hypoxia-Inducible Factor-1α, and Innate Antileishmanial Immune Responses
Schatz, V., Neubert, P., Rieger, F., & Jantsch, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00216 · Cited by 25
Cvitaš, I., Oberhänsli, S., Leeb, T., Dettwiler, M., Müller, E. J., Bruggmann, R., & Marti, E. (2020) · PLoS ONE · doi:10.1371/journal.pone.0232189 · Cited by 24
Hypoxic State of Cells and Immunosenescence: A Focus on the Role of the HIF Signaling Pathway
Troise, D. E., Infante, B., Mercuri, S., Netti, G. S., Ranieri, E., Gesualdo, L., Stallone, G., & Pontrelli, P. (2023) · Biomedicines · doi:10.3390/biomedicines11082163 · Cited by 22
Zhang, Y., Ren, Y., Chen, X., Deng, S., & Lü, W. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7232457 · Cited by 23
“These components act as proin fl ammatory and immunogenic agonists recognized by pattern recognition receptors (PRRs) expressed in immune cells, such as Mø and DCs [119].”
InfluentialMöllerherm, H., Meier, K., Schmies, K., Fuhrmann, H., Naim, H. Y., von Köckritz‐Blickwede, M., & Branitzki‐Heinemann, K. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01665 · Cited by 21
“, IL-6, TNF-α, and IL-1β under low oxygen concentrations (defined as 1% O2), proving that hypoxia has a major influence on cytokine production (48).”
BackgroundAkinsulie, O. C., Shahzad, S., Ogunleye, S. C., Oladapo, I. P., Joshi, M., Ugwu, C. E., Gbadegoye, J. O., Hassan, F. O., Adeleke, R. A., Akande, Q. A., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1224102 · Cited by 19
Is nuclear sirtuin SIRT6 a master regulator of immune function?
Pillai, V. B., & Gupta, M. P. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00483.2020 · Cited by 19
Yuan, Y., Tan, L., Wang, L., Zou, D., Liu, J., Lu, X., Fu, D., Wang, G., Wang, L., & Wang, Z. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.814621 · Cited by 17
“HIF-1α reportedly promoted migration of DCs via the chemokine receptor CCR7, and stimulated their maturation by enhancing the expression of costimulatory molecule CD86 (Kohler et al., 2012), consistent with the elevation of costimulatory molecules in Figure 7B.”
BackgroundHypoxia inducible factor prolyl hydroxylases in inflammatory bowel disease
Lun, J., Zhang, H., Guo, J., Yu, M., & Fang, J. S. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1045997 · Cited by 16
“In dentric cells activation of HIF-1α promotes production of interferon, IL-22 and IL-10 and induces cell differentiation as well as cell migration (Köhler et al., 2012; Naldini et al., 2012; Wobben et al., 2013).”
BackgroundThe cell stress and immunity cycle in cancer: Toward next generation of cancer immunotherapy
Laureano, R. S., Vanmeerbeek, I., Sprooten, J., Govaerts, J., Naulaerts, S., & Garg, A. D. (2023) · Immunological Reviews · doi:10.1111/imr.13287 · Cited by 13
“…receptor (CCR7), a chemokine receptor which is essential for the trafficking of DCs to the lymph nodes, is downregulated in hypoxic DCs. 109,110 On the other hand, the production of inflammatory cytokines such as tumor necrosis factor (TNF) and Type I IFNs might be increased, together with…”
BackgroundSung, J., & Kim, E. T. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07244-1 · Cited by 15
“Hypoxia-inducible factors (HIF-1α and HIF-2α) mediate immune suppression by upregulating VEGF, PD-L1, CD73, and adenosine receptors, which collectively blunt T cell activation and promote immune exclusion [69–72].”
Electrophile Modulation of Inflammation: A Two-Hit Approach
O’Brien, J. P., & Wendell, S. G. (2020) · Metabolites · doi:10.3390/metabo10110453 · Cited by 11
Functional Repercussions of Hypoxia-Inducible Factor-2α in Idiopathic Pulmonary Fibrosis
Torres-Soria, A. K., Romero, Y., Balderas-Martínez, Y. I., Velázquez‐Cruz, R., Espíndola, L. M. T., Camarena, Á., Flores‐Soto, E., Solís‐Chagoyán, H., Ruiz, V., Carlos‐Reyes, Á., et al. (2022) · Cells · doi:10.3390/cells11192938 · Cited by 12
Dendritic cells metabolism: a strategic path to improve antitumoral DC vaccination
Currivan, E., Finlay, D. K., & Moreira, D. (2022) · Clinical & Experimental Immunology · doi:10.1093/cei/uxac048 · Cited by 15
Oxygen-Mediated Molecular Mechanisms Involved in Intestinal Ischemia and Reperfusion Injury
Barakakis, P. A., Mavridis, T., & Chalkias, A. F. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178398 · Cited by 10
Oh, T., Kim, M.-W., Kang, G.-S., Ye, S., Choi, C., Park, W., Hay, M. P., Hirata, H., & Ahn, G. (2025) · Cancer Research and Treatment · doi:10.4143/crt.2025.200 · Cited by 8
Roles of hypoxia inducible factors in viral infection: Are they a potential therapeutic target?
Jia, S., Pan, S., Gao, Z., Qiao, H., Zhao, Y. M., Chuai, X., & Li, J. (2025) · Virulence · doi:10.1080/21505594.2025.2546680 · Cited by 8
“Research confirms HIF-1α’s involvement in regulating DC migration, differentiation, glycolysis reprogramming, and hypoxic survival [51–53].”
The role of glycolysis in inflammation
Dehantschutter, E. T., & Taylor, C. T. (2026) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00113.2026 · Cited by 8
Intracellular checkpoints for NK cell cancer immunotherapy
Huang, Y., Tian, Z., & Bi, J. (2024) · Frontiers of Medicine · doi:10.1007/s11684-024-1090-6 · Cited by 7
Heim, C., Motsch, B., Jalilova, S., Bernhardt, W. M., Ramsperger-Gleixner, M., Burzlaff, N. I., Weyand, M., Eckardt, K., & Ensminger, S. M. (2016) · Transplant Immunology · doi:10.1016/j.trim.2016.08.007 · Cited by 7
Immunogenicity is preferentially induced in sparse dendritic cell cultures
Nasi, A., Bollampalli, V. P., Sun, M. Y., Chen, Y., Amu, S., Nylén, S., Eidsmo, L., Rothfuchs, A. G., & Réthi, B. (2017) · Scientific Reports · doi:10.1038/srep43989 · Cited by 7
Donor-Specific Blood Transfusion in Lung Transplantation
Jin, X., Pirenne, J., Vos, R., Hooft, C., Kaes, J., Slambrouck, J. V., Kortleven, P., Vandervelde, C. M., Beeckmans, H., Kerckhof, P., et al. (2024) · Transplant International · doi:10.3389/ti.2024.12822 · Cited by 4
Mazzeo, R. S., & Swenson, E. R. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8772-2_14 · Cited by 4
Ropa, J. P., Trinh, T. L. P., Aljoufi, A., & Broxmeyer, H. E. (2021) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000645 · Cited by 4
Li, C., Qin, C., Li, X., Wang, J., Li, Y., & Sun, Q. (2026) · International Journal of Oncology · doi:10.3892/ijo.2026.5845 · Cited by 3
“By contrast, the mRNA expression of CCL18, CCL23, CCL26 and CCL24 is decreased; these downregulated genes are involved in the recruitment of other inflammatory leukocytes and a decrease in their expression leads to impaired recruitment ability (124,125).”
Wang, Y., & Zhou, F. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1605669 · Cited by 5
Hypoxia in the Pathophysiology of Inflammatory Bowel Disease
Morales, M., & Xue, X. (2023) · Comprehensive physiology · doi:10.1002/cphy.c220002 · Cited by 3
Doraneh-Gard, F., Amberger, D. C., Amend, C., Weinmann, M., Schwepcke, C., Klauer, L. K., Schutti, O., Hosseini, H., Kraemer, D. M., Rank, A., et al. (2024) · Cancers · doi:10.3390/cancers16132383 · Cited by 4
Modulation of Innate Immunity by Hypoxia
Riboldi, E., & Sica, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801968-9.00004-0 · Cited by 3
Missaglia, M., Filippi, M., Esposito, F., & Giordano, A. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-03021-6 · Cited by 2
Recent advances in immunotherapy-involved combination cancer therapy based on ZIF-8
Wang, G., Li, L., Wang, J., Liu, C., Li, C., & Zheng, X. (2024) · AIP Advances · doi:10.1063/5.0232660 · Cited by 3
Morel, L. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47927-1.00013-x · Cited by 2
Afşar, B., & Afşar, R. E. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00497-x · Cited by 2
“HIF-1α plays a role in the migration of dendritic cells (DC), which was evidenced by impaired migration of DCs (both in vivo and in vitro) in DC-specific HIF-1α deficient mice [66, 67].”
BackgroundBcl‐3 puts the brakes on contact hypersensitivity
Weighardt, H., & Förster, I. (2015) · European Journal of Immunology · doi:10.1002/eji.201545524 · Cited by 1
Self-citationDeletion of HIF-2α in Dendritic Cells Attenuates Anti-Glomerular Basement Membrane Nephritis
Miao, J., Qu, J., Li, D., & Zhang, M. (2025) · Biomedicines · doi:10.3390/biomedicines13040888 · Cited by 1
Wei, X., Shi, W., Dong, X., Kong, W., Dong, L., Zhang, L., Maimaitituerxun, A., Hou, C., Li, D., Liu, J., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1752864 · Cited by 1
“Kohler et al. demonstrated that hypoxia differentially regulates chemokine expression in bone marrow-derived dendritic cells via a HIF-1-dependent mechanism, increasing CCR7 expression and promoting the production of CCL17 and CCL22 (50).”
Bioengineered cryogels overcome hypoxia-driven tolerance and restore antitumor immunity
Bhatt, K., Colombani, T., Nukovic, A., Parekh, N. A., Hamrangsekachaee, M., Rogers, Z. J., Sitkovsky, M. V., Hatfield, S. M., & Bencherif, S. A. (2026) · Cell Biomaterials · doi:10.1016/j.celbio.2026.100417 · Cited by 2
Dendritic Cell Dysfunction Underlies Immune Escape After Adoptive Cellular Therapy in Glioblastoma
Jin, D., DiVita, B., Reid, A., Figg, J., Francis, C., Font, L. F., Love, C., Long-James, K., Hilferty, D., Stansbury, S. M., et al. (2026) · Cancers · doi:10.3390/cancers18162669 · Cited by 1
“Some studies report that hypoxia impairs DC maturation, antigen presentation, and T cell priming [11–13], whereas others suggest it may enhance DC migration and activation [14,15].”
Mitrakas, A. G., Giatromanolaki, A. N., & Koukourakis, M. I. (2023) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2023.2204944 · Cited by 1
Metadata
- Authors
- Köhler, T., Reizis, B., Johnson, R. S., Weighardt, H., & Förster, I.
- Affiliations
- Leibniz Institute of Environmental Medicine (DE)
- Columbia University (US)
- University of Cambridge (GB)
- Corresponding author
- Förster, Irmgard
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2012-04-26
- Volume
- 42
- Issue
- 5
- Pages
- 1226-1236
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- PMC
- PMC6592818
- OpenAlex
- W1559974225
- Cited by
- 108
- References
- 48
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 7 · 2023: 12 · 2022: 7 · 2021: 9 · 2020: 10 · 2019: 8 · 2018: 6 · 2017: 7 · 2016: 9 · 2015: 7 · 2014: 4 · 2013: 4
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (DFG) (FO178/2-2)
- SFB 704 (A1)
- GK1427
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- hypoxia-inducible factor-1α, dendritic cells, dendritic cell differentiation, dendritic cell migration, hypoxia, conditional knockout mice, MHC class II, CD86, cytokine production, IL-22, CCR7, CCL17, CCL22, chemokines, inflammatory processes
- MeSH terms
- Animals, Histocompatibility Antigens Class II, Bone Marrow Cells, Cell Differentiation, Cell Movement, Cells, Cultured, Dendritic Cells, Cell Hypoxia, Cytokines, Mice, Hypoxia-Inducible Factor 1, alpha Subunit, B7-2 Antigen, Receptors, CCR7
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.